Disease Info Card

Type Ii Mucolipidosis

Information about Type Ii Mucolipidosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Type Ii Mucolipidosis

Most recent studies have shown that Type Ii Mucolipidosis shares some biological mechanisms with dysostoses, galactosialidosis, gangliosidoses, gangliosidosis-gm1, gaucher-disease, inborn-errors-of-metabolism, lipoidosis, lysosomal-storage-diseases, metabolic-diseases, mucolipidoses, mucopolysaccharidoses, mucopolysaccharidosis-i, mucopolysaccharidosis-ii, neuraminidase-1-deficiency, niemann-pick-diseases, pfaundler-hurler-syndrome, pseudo-hurler-polydystrophy, sandhoff-disease, storage-disease, type-i-mucolipidosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Type Ii Mucolipidosis, and have been seen in publications frequently: Cell Death, Cell Proliferation, Cholesterol Esterification, Chondrocyte Differentiation, Endocytosis, Excretion, Glycosylation, Intracellular Transport, Localization, Myoblast Fusion, Ossification, Pathogenesis, Pinocytosis, Proteolysis, Receptor Recycling, Receptor-mediated Endocytosis, Secretion, Secretion Of Lysosomal Enzymes, Tooth Eruption, Transport

Quite a number of genes have been found to play important roles in Type Ii Mucolipidosis, such as ARSA, ASAH1, CTSB, CTSD, CTSH, GBA, GLB1, GNPTAB, GNPTG, GUSB, M6PR, MTCH1, NAGPA, PSAP, SMPD1, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.